Sermorelin, Ipamorelin Blend is a two-component peptide preparation supplied exclusively for controlled laboratory research. Each vial contains 5mg of Sermorelin and 5mg of Ipamorelin in lyophilized powder form.
Sermorelin is a synthetic analog of growth hormone-releasing hormone commonly referenced in laboratory research involving GHRH-receptor systems. Ipamorelin is a synthetic peptide ligand commonly examined in research involving the growth hormone secretagogue receptor, also identified as GHS-R1a.
The combined preparation provides a standardized research material for in-vitro experiments involving GH-axis assay systems, receptor activity, ligand interactions, analytical comparison, and multi-pathway signaling models. Experimental parameters, controls, concentrations, and analytical methods must be independently established by qualified laboratory personnel.
Lot-specific analytical documentation is available through the Nordsci COA Library. Documentation may include identity, purity, and analytical testing information applicable to the individual production lot.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Sermorelin, Ipamorelin (5mg / 5mg) Blend is a lyophilized, two-component peptide preparation intended exclusively for in-vitro laboratory research and analytical evaluation. The formulation contains equal labeled quantities of Sermorelin and Ipamorelin.
This material may be incorporated into controlled experimental models involving GHRH-receptor systems, GHS-R1a receptor systems, ligand-receptor interactions, analytical method development, and comparative GH-axis research. The blend format allows both peptide components to be evaluated within the same defined research material.
The product is not supplied with protocols for dosing, administration, clinical application, human use, veterinary use, or other in-vivo procedures. Researchers are responsible for determining suitable experimental controls, analytical methods, laboratory conditions, and institutional requirements.
Sermorelin, Ipamorelin (5mg / 5mg) Blend – Research Specifications:
| Product Name | Sermorelin, Ipamorelin Blend |
| Format | Lyophilized peptide blend |
| Contents | Sermorelin (5mg) and Ipamorelin (5mg) |
| Component Type | Synthetic peptide research materials |
| Molecular Formula | A single molecular formula is not applicable to this two-component blend. Consult component-specific and lot-specific documentation. |
| Molecular Weight | A single molecular weight is not applicable to this two-component blend. Consult component-specific and lot-specific documentation. |
| CAS Information | Refer to component-specific and lot-specific documentation where available. |
| Sequence Information | Refer to component-specific analytical documentation. |
| Appearance | Lyophilized powder |
| Purity and Identity | Refer to the lot-specific Certificate of Analysis. |
| Analytical Testing | Testing methods and results are identified in the applicable COA, including HPLC or mass-spectrometry data where documented. |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture. Use controlled frozen storage for longer-term retention. |
| Permitted Use | In-vitro laboratory research and analytical evaluation only. |
| Prohibited Uses | Human use, animal use, diagnostic use, therapeutic use, food use, cosmetic use, supplement use, and clinical application. |
Sermorelin is a synthetic peptide analog associated with laboratory investigation of the growth hormone-releasing hormone receptor. In controlled research environments, it may be used as a reference material in receptor characterization, binding studies, assay development, and GH-axis pathway research.
Ipamorelin is a synthetic peptide ligand associated with the growth hormone secretagogue receptor, commonly designated GHS-R1a. Laboratory investigations may use Ipamorelin in receptor-binding assays, pathway-selectivity experiments, analytical comparisons, and studies of ligand-dependent assay behavior.
Combining the two compounds creates a defined research material containing ligands associated with two separate receptor systems. This format may be used in controlled in-vitro experiments examining assay interactions, analytical differentiation, receptor-system comparisons, and research methodologies involving multiple peptide components.
Researchers requiring either material separately may reference the individual product pages for Sermorelin and Ipamorelin.
Important Research Notice: Nordsci peptide products are accompanied by lot-specific analytical documentation when available. Researchers should use the COA associated with the exact lot received for procurement review, identity verification, and internal recordkeeping.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR IN-VITRO LABORATORY RESEARCH. IT IS NOT FOR HUMAN OR ANIMAL CONSUMPTION, HUMAN OR VETERINARY IN-VIVO USE, OR DIAGNOSTIC, THERAPEUTIC, CLINICAL, FOOD, COSMETIC, OR SUPPLEMENT APPLICATIONS.
The blend may be evaluated in controlled laboratory systems designed to examine GH-axis assay behavior and time-dependent analytical measurements. Research teams must establish appropriate controls, sampling frameworks, measurement criteria, and validation procedures for each experimental design.
This product is not intended for experiments involving human administration, animal administration, or the evaluation of consumer outcomes.
Sermorelin and Ipamorelin are associated with separate receptor systems commonly referenced in GH-axis research. The blend may be used in in-vitro models examining receptor-specific pathways, multi-ligand assay conditions, or interactions between defined signaling components.
Any observations are limited to the experimental model, conditions, controls, and analytical methods used. Laboratory findings must not be interpreted as evidence of safety, efficacy, or suitability for human or veterinary use.
Qualified laboratories may use the blend when developing or validating analytical methods involving GH-axis research markers. Potential applications include assay qualification, reference comparisons, analytical detection, time-course measurement, and evaluation of controlled experimental variables.
The material is not supplied for clinical biomarker testing, patient monitoring, diagnostic procedures, or treatment-related applications.
The two-component format may be compared with appropriately controlled single-component research materials. Such experiments can help researchers differentiate component-specific assay activity from observations associated with a combined preparation.
Comparative experiments should document material identity, lot information, test conditions, controls, instrumentation, acceptance criteria, and analytical limitations.
Handle Sermorelin, Ipamorelin Blend in accordance with established laboratory procedures for synthetic peptide research materials. Appropriate practices include controlled access, contamination prevention, calibrated equipment, documented storage conditions, lot tracking, and compliant disposal.
Only qualified professionals operating within properly equipped research facilities should handle this product. Personnel must follow applicable institutional policies, chemical hygiene plans, occupational safety requirements, and local regulations.
Protocol Design Considerations: Experimental results may be affected by material concentration, assay design, sample preparation, timing, temperature, instrumentation, controls, and other laboratory variables. These factors should be documented and independently validated before results are interpreted.
No information on this page constitutes dosing, preparation, administration, human-use, animal-use, medical, veterinary, or clinical guidance.
Note: All product information is provided solely for laboratory procurement, identification, storage, and research-planning purposes.
Lot-specific Certificates of Analysis provide the analytical information available for a particular production lot. Depending on the testing performed, documentation may include identity, purity, chromatographic data, mass-spectrometry data, or other quality-control results.
Researchers should verify that the lot number shown on the product corresponds with the lot number identified in the analytical documentation. COA information is intended to assist with procurement review, laboratory recordkeeping, material verification, and research reproducibility.
A Certificate of Analysis does not establish that the product is safe, effective, approved, or suitable for human, animal, diagnostic, therapeutic, or clinical use.
Nordsci Peptides supplies Sermorelin, Ipamorelin Blend as a research material for qualified laboratories and research organizations. Each vial contains 5mg of Sermorelin and 5mg of Ipamorelin in lyophilized form.
Laboratories evaluating peptide suppliers should review product identity, labeled contents, lot traceability, storage requirements, analytical documentation, and applicable institutional procurement standards before ordering.
IMPORTANT: This product is sold exclusively for in-vitro laboratory research and analytical use. It is not approved or intended for human consumption, animal consumption, human or veterinary in-vivo use, diagnosis, treatment, prevention, clinical application, food use, cosmetic use, or dietary-supplement use. The purchaser is responsible for lawful procurement, storage, handling, experimentation, and disposal.
